XENE Stock Predictions
| Recent XENE Stock Price | XENE Stock Predictions | |
| $40.50 |  +41.98% |
$57.50 |
| Recent XENE Analyst Ratings Breakdown, Making XENE Stock Predictions | ||||
|---|---|---|---|---|
| Current | 1 Mo. Ago | 2 Mo. Ago | 3 Mo. Ago | |
| Strong buy ratings: | 15 | 15 | 15 | 15 |
| Buy ratings: | 3 | 3 | 3 | 3 |
| Hold ratings: | 0 | 0 | 0 | 0 |
| Sell ratings: | 0 | 0 | 0 | 0 |
| Strong sell ratings: | 0 | 0 | 0 | 0 |
| Average rating: | 1.17 | 1.17 | 1.17 | 1.17 |
For the XENE stock predictions from the analysts covering Xenon Pharmaceuticals Inc, we have collected all of the individual XENE stock predictions for stock price one year from now (i.e. each analyst's "forward price target") and at the top of this page we have presented the average prediction across the 15 different analysts covering XENE (as reported in
data provided by Zacks Investment Research via Quandl.com).
But since XENE stock predictions may vary widely, another useful metric to consider is the median XENE stock prediction, which represents the price at which half of the analysts
made XENE stock predictions that were higher and half made XENE stock predictions that were lower. This makes for a different take on the XENE stock predictions out there, as compared to average or mean.
And that median across all the individual XENE stock predictions was: $60.0 as of 2024-04-29.
The very highest of the XENE stock predictions for one year price target was $65.0, while the very lowest of the XENE stock predictions in the analyst group was
$48.0 (with a standard deviation of $5.308). Get the latest Zacks research report on XENE — FREE
Dividend Growth Stocks: 25 Aristocrats
10 Dividend Bargains You Can Buy Cheaper Than Insiders Did
Other stock predictions:
• SACH Stock Predictions
• UFI Stock Predictions
• APLT Stock Predictions
• PE Stock Predictions
• SSD Stock Predictions
• MDB Stock Predictions
• TCOM Stock Predictions
• TRTN Stock Predictions
• GBCI Stock Predictions
|
|||||||||
|
|
|
|
|
|
Free XENE Email Alerts:
Avg. Broker Rec.
 
|
Strong Buy (3.83 out of 4) 75th percentile
(ranked higher than approx. 75% of all stocks covered)
Based on data provided by Zacks Investment Research via Quandl.com |
|
|
